Actively Recruiting
A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea
Led by Bristol-Myers Squibb · Updated on 2024-12-13
15
Participants Needed
5
Research Sites
341 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to monitor the long-term safety of participants who received idecabtagene vicleucel treatment as part of the KarMMa-9 (CA089-1043) Phase 3 clinical trial.
CONDITIONS
Official Title
A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 19 years of age or older
- Korean participants with newly diagnosed multiple myeloma
- Participants with suboptimal response after autologous stem cell transplantation
- Participants treated with idecabtagene vicleucel in the KarMMa-9 trial (CA089-1043)
- Ability to understand and voluntarily sign informed consent for the long-term follow-up study
You will not qualify if you...
- Participants in KarMMa-9 trial who do not agree to participate in long-term follow-up surveillance in Korea
- Participants unable to receive idecabtagene vicleucel within 9 days after completing lymphodepleting chemotherapy unless discussed with a medical monitor
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Chonnam National University Hwasun Hospital
Hwasun, Jeonranamdo, South Korea, 58128
Actively Recruiting
2
Seoul National University Hospital
Seoul, Seoul-teukbyeolsi [Seoul], South Korea, 03080
Actively Recruiting
3
Asan Medical Center
Seoul, Seoul-teukbyeolsi [Seoul], South Korea, 05505
Actively Recruiting
4
Samsung Medical Center
Seoul, Seoul-teukbyeolsi [Seoul], South Korea, 06351
Actively Recruiting
5
The Catholic Univ. of Korea Seoul St. Mary's Hospital
Seoul, Seoul-teukbyeolsi [Seoul], South Korea, 06591
Actively Recruiting
Research Team
B
BMS Study Connect Contact Center www.BMSStudyConnect.com
CONTACT
F
First line of the email MUST contain NCT # and Site #.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here